Clinical trials

63

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

IN PATIENTS WITH CORNEAL ABRASIONS TREATED WITH COLLAGEN CORNEAL SHIELDS IN THE EMERGENCY DEPARTMENT SETTING

This is a single-center, double-arm, patient masked, randomized controlled trial. Subjects will be enrolled in the Emergency Department at the Penn State Milton S. Hershey Medical Center. Eligible subjects must present to the ED and be diagnosed with a traumatic corneal abrasion. One eye from each patient will be considered the study eye.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jul 13, 2026
Eligibility criteria

Male or female, age 18 or older at the time of study enrollment. [+3]

Corneal abrasion in both eyes. [+13]

Status: Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

The purpose of this study is to evaluate the investigational drug, silmitasertib (a pill taken by mouth), in combination with FDA approved drugs for solid tumors. An investigational drug is one that has not been approved by the U.S. Food \& Drug Administration (FDA), or any other regulatory authorities around the world for use alone or in combination with any drug, for the condition or illness it is being used to treat. The goals of this part of the study are: * Establish a recommended dose of silmitasertib in combination with chemotherapy * Test the safety and tolerability of silmitasertib in combination with chemotherapy in subjects with cancer * To determine the activity of study treatments chosen based on: * How each subject responds to the study treatment * How long a subject lives without their disease returning/progressing

Participants needed: 104
Trial details
Phase: Phase 1, Phase 2Age: Up to 30Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jul 2, 2026Locations: 22
Eligibility criteria

Age: Less than 30 years old at initial diagnosis [+26]

Investigational Drugs: Subjects who are currently receiving another investigatio... [+12]

Status: Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (DFMO). An investigational drug is one that has not been approved by the U.S. Food \& Drug Administration (FDA), or any other regulatory authorities around the world for use alone or in combination with any drug, for the condition or illness it is being used to treat. The goals of this part of the study are: * Establish a recommended dose of AMXT 1501 in combination with DFMO * Test the safety and tolerability of AMXT 1501 in combination with DFMO * To determine the activity of study treatments chosen based on: * How each subject responds to the study treatment * How long a subject lives without their disease returning/progressing

Participants needed: 289
Trial details
Phase: Phase 1, Phase 2Age: Up to 26Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jul 1, 2026Locations: 12
Eligibility criteria

Safety Run-in (Dose level 1)-The first three (3) participants enrolled will be ≥... [+29]

BSA of <0.25 m2 [+4]

Status: Recruiting

Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients

This is a pilot feasibility study examining the use of immersive virtual reality (VR) in adult intensive care unit (ICU) patients. The study evaluates whether brief, non-interactive VR sessions delivered using a commercially available standalone head-mounted display with calming, nature-based content can be delivered safely and effectively within routine SICU workflow. Exploratory objectives assess whether VR sessions are associated with changes in anxiety, agitation, delirium, pain, and sedative medication requirements. This research is not intended to evaluate the safety or effectiveness of the headset and/or the specific VR software used for the research

Participants needed: 30
Trial details
Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 22, 2026Locations: 1
Eligibility criteria

Aged ≥ 18 years old admitted to the Surgical Intensive Care Unit (SICU) at Penn... [+4]

Significant hemodynamic instability [+4]

Status: Not yet recruiting

Impact of Electronic Cigarette Temperature and Solvent on Biomarkers

This project seeks to determine how e-cigarette (EC) physical design features, including those that allow the user to manipulate the quality and quantity of aerosols, affect exposure and toxicity from oxidants and other aerosol constituents.

Participants needed: 50
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 16, 2026Locations: 1
Eligibility criteria

21 years of age or older [+6]

Women who are pregnant and/or nursing or trying to become pregnant [+4]

Status: Not yet recruiting

Penn State Emergency Medicine CarES: Care-partner Evaluation and Sourcing in the Emergency Department

Care partners of people living with dementia often experience ongoing stress and unmet support needs. This study evaluates the feasibility of a low-intensity, supportive education and resource intervention for care partners who previously participated in an observational study. Participants complete a baseline phone interview and a short stress journaling activity, followed by a six-week series of automated educational and supportive messages delivered by text message or email. Participants may also take part in an optional peer support focus group. The study examines caregiver stress, resilience, engagement with resources, and participant feedback to inform future caregiver support interventions.

Participants needed: 20
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 15, 2026Locations: 1
Eligibility criteria

Person completed the CarES Observational Study. [+3]

Person is no longer a care partner for a person living with dementia [+1]

Status: Recruiting

Little Cigar Oxidants

Determine the effects of little cigars on human exposure to tobacco smoke oxidants. In a balanced randomized cross-over study design in cigarette smokers, subjects will be assigned to 3 exposure groups. These include a high oxidant little cigar exposure condition, a low oxidant little cigar exposure condition, and their usual cigarette. Biological samples will be collected before and after product usage.

Participants needed: 50
Trial details
Age: 21-65Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 16, 2026Locations: 1
Eligibility criteria

Aged 21 - 65 years old [+7]

Women who are pregnant and/or nursing or trying to become pregnant [+4]

Status: Recruiting

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Ewing sarcoma (EWS) and osteosarcoma primarily affect adolescents and young adults. Common treatments include chemotherapy, surgery and radiation, however, there have been few recent advancements in the standard of care. By incorporating eflornithine (DFMO) as an additional therapy and/or maintenance therapy we hope to safely observe improved event-free survival and overall survival. There are 5 cohorts covered under this master protocol.

Participants needed: 406
Trial details
Phase: Phase 2Age: 0-50Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 12, 2026Locations: 2
Eligibility criteria

Participants must be ≤50 years of age at enrollment. [+20]

BSA of <0.25 m2 [+91]

Status: Recruiting

Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy

The purpose of this study is to assess pharmacokinetics of liposomal bupivacaine (Exparel) after multilevel intercostal injections of this local anesthetic for pain control during and after thoracoscopic surgeries. The specific aim of this study is to evaluate plasma concentration of bupivacaine after intraoperative intercostal injections of 266 mg of liposomal bupivacaine and compare it to plasma concentrations of bupivacaine after intercostal injections of 2mg/kg of 0.5% plain Bupivacaine with maximal dose of 30 ml or 150 mg. The hypothesis of the study is that plasma concentration of bupivacaine after intercostal injections of 266 mg of liposomal bupivacaine will be similar to concentrations after injections of plain bupivacaine, and will remain below the toxic level threshold range of 2000-3000 ng/mL (2-3 mg/L) at which central nervous system and cardiovascular adverse events would be expected to occur. The secondary objective is to evaluate if intercostal injections of 266 mg of liposomal bupivacaine will significantly reduce opioid consumption and postsurgical pain, within the first 48 hours and up to 3 months after minimally invasive thoracic surgeries, to determine if both acute and chronic post-thoracotomy pain can be decreased by intraoperative intercostal injections of liposomal bupivacaine. Additionally, the rate of pneumonia, the rate of atrial fibrillation and length of hospital stay will be assessed as secondary outcomes after thoracic surgeries. These outcomes can be affected by the level of postoperative pain and inflammation. Significance of this study: If positive, the results of this research have the potential to significantly improve pain management after thoracoscopic surgery. Based on prior experience, prolonged analgesia after liposomal bupivacaine injection is safe, and may help reduce perioperative opioid consumption and decrease opioid related complications. It will improve patient comfort, eliminate need for indwelling neuraxial catheters and risks associated with them.

Participants needed: 40
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 12, 2026Locations: 1
Eligibility criteria

VATS wedge resection /segmentectomy [+3]

Patients under18 years of age [+13]

Status: Not yet recruiting

Mitigating Burnout in Nursing and Associated Healthcare Staff

Workplace stress for healthcare workers is at an all-time high and the COVID-19 Pandemic magnified and amplified the impact of stress and burnout on health care workers, especially for frontline staff such as nurses. There are multiple external and individual factors that affect clinician well-being, and organizational factors are an important aspect to address when attempting to mitigate nurse burnout and improve well-being. This project seeks to expand two interventions that were piloted in the last few years since the Covid-19 Pandemic, validated to show improvement in staff well-being and decreased feelings of burnout following the interventions, and are easily implemented to benefit nurses and other multidisciplinary health care workers and students in both the inpatient and outpatient settings.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 5, 2026
Eligibility criteria

Not listed

Status: Recruiting

Ultrasound (US) Guided External Ventricular Catheter Placement

To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular drain into the cranial cavity. This study will aim at evaluating the proposed efficacy of the device in targeting the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.

Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

Decision made to perform the procedure by the primary consultant [+7]

Age <18 [+4]

Status: Recruiting

Evaluation of Structural and Functional Integrity of the Rotator Cuff After Total Shoulder Arthroplasty

The purpose of this study is to examine the rotator cuff muscles in your shoulder at one and two year post total shoulder replacement surgery.

Participants needed: 30
Trial details
Age: 45+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

age >45yrs [+6]

Known contraindications to CT/EMG [+6]

Status: Not yet recruiting

Transdiagnostic Sleep and Circadian Treatment for Autistic Adolescents

Sleep and circadian problems are associated with deleterious social, emotional, and cognitive outcomes, yet are modifiable. This prospective study will adapt and optimize an empirically supported behavioral intervention that addresses common sleep and circadian problems of autistic adolescents, who are at increased risk for mental health disorders, using a transdiagnostic approach. The knowledge gained from this study will help to address a critical need for accessible transdiagnostic sleep interventions for autistic adolescents, who experience a broad range of sleep and circadian problems at high rates and often lack access to specialty care treatment.

Participants needed: 12
Trial details
Age: 13-17Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 4, 2026
Eligibility criteria

Autistic adolescents diagnosed with Autism Spectrum Disorder (ASD). [+5]

A history of Intelligent Quotient (IQ) < 70. [+2]

Status: Recruiting

Autonomic Control of the Circulation and VDR

The study objective of this project is to examine the mechanisms of the venous distension reflex (VDR) in humans. We hypothesize that COX blockade with ketorolac tromethamine, an intravenous NSAID, will attenuate the muscle sympathetic nerve activity (MSNA) response to limb venous distension. To gain further insight into whether the COX byproducts directly stimulate chemically-sensitive afferents, or enable venodilation and indirectly evoke afferent stimulation, we will measure vein size using 3T MRI during venous distention with and without ketorolac infusions.

Participants needed: 18
Trial details
Phase: Early Phase 1Age: 21-35Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Jun 2, 2026Locations: 1
Eligibility criteria

Are capable of giving informed consent [+3]

Are free of acute or chronic medical conditions [+15]

Status: Recruiting

AYA-PeerConnect: A Communication Coaching Intervention for Adolescent/Young Adult Cancer Survivors (AYACS)

This research is being done to test a communication coaching intervention pilot designed to improve communication quality between adolescent/young adult cancer survivors (AYACS) and their friends/peers. The results of the study will help to understand how to best support adolescent/young adult cancer survivors, and may inform the development or future implementation of similar programs for cancer survivor populations.

Participants needed: 10
Trial details
Age: 18-35Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: May 22, 2026Locations: 1
Eligibility criteria

Participant is currently ≥18-35 years old [+4]

Participant is not fluent in written and spoken English [+2]

Status: Recruiting

The Impact of Yoga on Endometriosis-Related Pain

The central hypothesis of the investigators is that the practice of yoga will result in an improvement of endometriosis related pain symptoms for women with endometriosis.

Participants needed: 30
Trial details
Age: 18-45Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: May 22, 2026Locations: 1
Eligibility criteria

Reproductive aged women 18-45 [+6]

Pregnant patients [+4]

Status: Not yet recruiting

Amino Acid Infusion in Cardiac Surgery

The goal of this study is to see if an infusion of amino acids given to adult male and female patients during cardiac surgery can help prevent acute kidney injury that commonly occurs when patients undergo cardiac surgery needing cardiopulmonary bypass. The main question the study aims to answer is if a short infusion of amino acids given to study participants during their scheduled heart surgery can decrease rates of acute kidney injury - which will be measured by biological markers of kidney injury in the urine. The study will be conducted in 2 phases. Participants in the first phase will receive the current standard of anesthetic care for patients having heart surgery and markers of acute kidney injury will be measured before and after their surgery. Participants in the second group will receive the anesthetic standard of care plus a short infusion of amino acids during their surgery. They will also have markers of kidney injury measured before and after their surgery. This study is based on prior studies that showed amino acid infusions are protective against kidney injury; however, these past studies did not look at markers of kidney injury in the urine.

Participants needed: 130
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: May 13, 2026
Eligibility criteria

Male and female patients 18 years of age or older undergoing elective cardiac su... [+3]

Preoperative or planned post-operative need for renal replacement therapy. [+7]

Status: Recruiting

Diabetes Clinical Decision Support

The purpose of this study is to determine the impact of an electronic medical record clinical decision support tool on rates of dysglycemia in the hospital, and its clinical and economical outcomes. The study also evaluates the perspectives of providers regarding the tool's usefulness on disease management support, knowledge, and practice performance.

Participants needed: 15,732
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: May 14, 2026Locations: 2
Eligibility criteria

Hospitalized adult (>18 years) patients at Penn State Health, Hershey Medical Ce... [+2]

Children (<18 years)

Status: Not yet recruiting

Comparative Effectiveness of Two Different Approaches to Radiofrequency Ablation of Lumbar Medial Branch Nerves

The purpose of this voluntary research study is to determine whether the parasagittal approach to lumbar medial branch (LMB) nerve radio frequency ablation (RFA) will have greater efficacy than the traditional approach to lumbar medial branch nerve radio frequency ablation.

Participants needed: 25
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: May 12, 2026Locations: 1
Eligibility criteria

Bilateral equally intense axial low back pain [+5]

Radicular pain below the knee [+11]

Status: Recruiting

CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy

The goal of this clinical trial is to learn if a commercially available cannabigerol (CBG)/cannabidiol (CBD) oil is safe, feasible to use, and can help reduce symptoms of chemotherapy-induced peripheral neuropathy (CIPN) in adults who have completed platinum-based chemotherapy for gastrointestinal cancers. The main questions it aims to answer are: Is CBG/CBD oil safe and well-tolerated over a 12-week treatment period? Can participants with CIPN use CBG/CBD oil consistently as part of their care? Does CBG/CBD oil help reduce pain, numbness, or other symptoms of CIPN? Participants will: Take CBG/CBD oil under the tongue (sublingually) twice daily for 12 weeks Complete regular symptom assessments and functional tests during study visits Provide blood samples for cannabinoid and metabolite level testing

Participants needed: 12
Trial details
Phase: Phase 1Age: 21+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: May 11, 2026Locations: 1
Eligibility criteria

Adults aged 21 years or older. [+6]

Patients under the age of 21 years. [+16]

Status: Recruiting

SSVC-CI During CABG

To investigate the superior vena cava collapsibility index (SVC-CI), measured via transesophageal echocardiography (TEE), as a marker of fluid responsiveness. Two groups will be compared in this study. Groups will be identified by obtaining cardiac output (CO) by standard means using the TEE or pulmonary arterial catheter (PAC). Both of these monitors are considered standard for patient's undergoing coronary artery bypass grafting surgery (CABG) and recording initial CO readings. Based on CO, the patient's will be placed in study groups one or two. Participants with normal and mildly reduced left ventricular ejection fraction (LVEF \&gt;40%) for group one and those with moderately to severely reduced LVEF (\&lt;40%) in the second group. Following group separation, we will measure the SVC-CI and CO metric in both groups. The intervention will be an operating room table tilt test (head up and then head down) to artificially simulate giving the patient additional fluid. Before and after table tilt, the SVC-CI and CO will be obtained and measured. The SVC-CI is a mathematical equation determined by distance measurements taken via TEE to identify how much the superior vena cava has collapsed following table tilt. Participants will be considered responders if the CO increases by 12% following intervention. Non responders less than 12% change in CO following intervention. Our hypothesis is that the SVC-CI can differentiate responders vs non-responders with regards to fluid responsiveness with adequate sensitivity and specificity in participants with CAD undergoing isolated CABG. The SVC-CI numerical values for the two groups, responders and non-responders, will calculate a threshold of sensitivity and specificity percentages for future patients undergoing CABG.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Milton S. Hershey Medical CenterUpdated: May 7, 2026Locations: 1
Eligibility criteria

Age ≥ 18 [+3]

Age less than 18 years of age [+5]

Status: Recruiting

Pain and Disability Outcomes in Post Amputation Patients

The objective of this study is to evaluate efficacy of varied medical and procedural therapies used to treat pain after surgical amputation of a limb. The primary outcome will be assessment of pain severity at rest and with movement as measured by pain scores on Numerical Rating Scale (NRS) 0 to 10, where 0 is not pain and 10 is the worst pain possible, taken on post-operative day 1, day 7, 30 days, 90 days, 6 months, and 1 year (+/- 3 days at each time point).

Participants needed: 350
Trial details
Age: 18-89Biological sex: AllType: ObservationalSponsor: Milton S. Hershey Medical CenterUpdated: May 7, 2026Locations: 1
Eligibility criteria

Ages between 18 and 89 years old, inclusive [+1]

Patients who cannot cooperate or consent [+4]

Status: Recruiting

Impact of Parental Emotion Regulation on the Treatment of ADHD

Aim: To examine if parental emotion regulation (ER) moderates the response to parent training interventions. H1: Reduced parental ER capacity will predict diminished efficacy for behavioral parent training to improve negative parenting behavior (NPB) and behavior problems in offspring with ADHD. H2: Increased parental emotional reactivity will predict diminished efficacy for behavioral parent training to improve negative parenting behavior (NPB) and behavior problems in offspring with ADHD.

Participants needed: 65
Trial details
Age: 5-12Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: May 7, 2026Locations: 1
Eligibility criteria

Parent of a child ages 5-12 with ADHD [+1]

Not being the parent of a child ages 5-12 who meets diagnostic criteria for ADHD... [+4]

Status: Recruiting

Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

This Phase I/II open-label trial aims to evaluate the safety and efficacy of the herbal supplement INM176 in patients with a history of prostate cancer or low-risk disease under active surveillance. The study will determine the recommended Phase II dose (RP2D) and assess the efficacy of INM176 in stabilizing or decreasing plasma PSA levels in post-radical prostatectomy (RP) and post-radiation therapy (RT) patients with rising PSA levels.

Participants needed: 45
Trial details
Phase: Phase 1, Phase 2Age: 40+Biological sex: MaleType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

Willingness and ability to give informed consent. [+25]

Subjects with distant metastatic cancer. Node-positive prostate cancer patients... [+6]

Status: Not yet recruiting

Impact of Loss Aversion Messaging and Anticipated Regret for Inaction on Exercise Adherence in Older Adults

The goal of this clinical trial is to learn if messages focused on not losing the functional benefits of exercise can help older adults with walking difficulty continue to exercise regularly. The main questions it aims to answer are: Do these messages make people more likely to anticipate regretting it if they do not exercise? Does more anticipated regret make it more likely they will exercise more regularly? Researchers will compare two versions of messages to see if the content of these one of these message types is more effective than the other. Participants will complete a daily 5-minute at home exercise program for 4 months and complete regular online surveys to track their progress and report their feelings regarding regret.

Participants needed: 148
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Milton S. Hershey Medical CenterUpdated: Apr 20, 2026Locations: 1
Eligibility criteria

Completed 12 months of FAST intervention

No planned surgeries within the upcoming 4 months